Drug Interaction Between Ketoconazole and Cloxacillin
There is no clinically significant direct pharmacokinetic interaction between ketoconazole and cloxacillin that would contraindicate their concurrent use, but cloxacillin may reduce ketoconazole efficacy through enzyme induction, requiring monitoring of antifungal response.
Mechanism of Interaction
Ketoconazole is primarily metabolized through CYP3A4 and acts as a potent CYP3A4 inhibitor 1. The drug also inhibits P-glycoprotein transport 1. Cloxacillin (an isoxazolyl penicillin) has been identified as an enzyme inducer that can decrease exposure of drugs metabolized by CYP450 enzymes, diphosphate-glucuronosyltransferase enzymes, and P-glycoprotein 2.
Recent evidence demonstrates that isoxazolyl penicillins (including cloxacillin) can reduce exposure to various drugs through enzyme induction mechanisms 2, 3. When flucloxacillin (a closely related isoxazolyl penicillin) was studied with isavuconazole, it significantly decreased antifungal exposure 3.
Clinical Implications
Risk Assessment
- Ketoconazole efficacy may be reduced when combined with cloxacillin due to potential enzyme induction
- The interaction is bidirectional but asymmetric: cloxacillin affects ketoconazole more than ketoconazole affects cloxacillin
- Most concerning when ketoconazole is used for serious fungal infections where therapeutic failure could impact mortality
Monitoring Recommendations
Monitor antifungal activity closely when combining these agents 4:
- Assess clinical response to antifungal therapy
- Consider increasing ketoconazole dose if inadequate response (though this increases hepatotoxicity risk)
- If possible, measure ketoconazole plasma concentrations to guide dosing
Monitor for ketoconazole toxicity 1:
- Baseline and weekly liver function tests (AST, ALT, bilirubin)
- Discontinue if transaminases exceed 3× upper limit of normal
- Watch for signs of hepatotoxicity: unusual fatigue, anorexia, nausea/vomiting, jaundice, dark urine, pale stools
Monitor for cloxacillin toxicity 5, 6:
- Renal function monitoring, especially in elderly patients
- Acute kidney injury occurs in up to 84% of patients on high-dose cloxacillin (≥10-12 g/day)
- Risk factors include concomitant nephrotoxic drugs, renal impairment, and advanced age
Practical Management Algorithm
Assess necessity of combination:
- Can an alternative antibiotic be used instead of cloxacillin?
- Can an alternative antifungal (fluconazole, voriconazole) be used instead of ketoconazole?
If combination is necessary:
- Obtain baseline liver function tests before starting ketoconazole
- Monitor liver enzymes weekly during initial therapy
- Monitor clinical response to antifungal therapy closely
- Consider therapeutic drug monitoring of ketoconazole if available
Dose adjustment considerations:
Duration considerations:
- Single-dose or short-term combinations (<7 days) pose lower risk
- Enzyme induction requires sustained exposure to manifest fully 3
- Long-term combinations require more intensive monitoring
Important Caveats
Ketoconazole has significant limitations 4:
- Second-line antifungal due to variable absorption and hepatotoxicity risk
- FDA black box warning for severe hepatotoxicity
- Strongest CYP3A4 inhibitor among azoles, creating numerous drug interactions
Alternative antifungals should be strongly considered:
- Fluconazole is first-line for most candidal infections with better safety profile 4
- Voriconazole or itraconazole solution for refractory cases
- These alternatives have fewer interaction concerns with cloxacillin
High-dose cloxacillin carries independent risks 5, 6:
- Systematic overdosing occurs in 84% of ICU patients
- Acute kidney injury in elderly patients with concomitant nephrotoxic drugs
- Neurological side effects (persistent coma, delirium) in 17.7% of overdosed patients
The combination is not contraindicated but requires vigilant monitoring, particularly of antifungal efficacy and hepatic function. Consider alternative agents when feasible to avoid this interaction entirely.